logo
Where Are We Now With Bilirubin as a Marker of Vascular Risk?
No-Reflow Phenomenon: Pathophysiology, Diagnosis, Prevention, and Treatment. A Review of the Current Literature and Future Perspectives
Cost-Effectiveness of Cilostazol, Naftidrofuryl Oxalate, and Pentoxifylline for the Treatment of Intermittent Claudication in People With Peripheral Arterial Disease
Does Serum Bilirubin Level on Admission Predict TIMI Flow Grade and In-Hospital MACE in Patients With STEMI Undergoing Primary PCI
The Aberdeen Varicose Vein Questionnaire May be the Preferred Method of Rationing Patients for Varicose Vein Surgery
The Frequency of 4 Common Gene Polymorphisms in Nonagenarians, Centenarians, and Average Life Span Individuals
Neutrophil Gelatinase-Associated Lipocalin as an Early Marker of Contrast-Induced Nephropathy After Coronary Angiography
Is It Possible to Prevent Acute Kidney Injury in Patients Who Underwent Contrast Medium?
“Is It possible to Prevent Acute Kidney Injury in the Patients Who Underwent Contrast Medium?”
Association Between Uric Acid and Coronary Collateral Circulation in Patients With Stable Coronary Artery Disease
The Paradox of Uric Acid in Cardiovascular Diseases
Uric Acid As a Cardiovascular Risk Factor Or Not?
The Association of Serum Uric Acid Level With Coronary Collateral Circulation Should Be Interpreted Together With Renal Function and Cardiovascular Medications in Stable Coronary Artery Disease
Determinants That May Affect Serum Uric Acid Levels
Relationship Between Increased Serum Resistin Level and Severity of Coronary Artery Disease
Proprotein Convertase Subtilisin/Kexin Type 9: A Plausible Link Between Serum Resistin Levels and Cardiovascular Events
Proprotein Convertase Subtilisin/Kexin Type 9: A Plausible Link Between Serum Resistin Levels and Cardiovascular Events
Relation Between Serum Total Bilirubin Levels and Severity of Coronary Artery Disease in Patients With Non-ST-Segment Elevation Myocardial Infarction
The Prognostic Role of Serum Total Bilirubin in Non-ST Segment Elevation Myocardial Infarction: What About On-Admission Cardiovascular Medications?
Reply to the Letter to the Editor Entitled “The Prognostic Role of Serum Total Bilirubin in Non-ST-Segment Elevation Myocardial Infarction: What About On-Admission Cardiovascular Medications?” by Dr Canpolat
Mean Platelet Volume in Patients With Carbon Monoxide Poisoning
Mean Platelet Volume and Platelet Count Values in Patients with Carbon Monoxide Poisoning
Response to Letter to the editor: Mean Platelet Volume and Platelet Count Values in Patients With Carbon Monoxide Poisoning
Treat-to-Target Low-Density Lipoprotein Cholesterol: Time to Debate a Too Simple and Dogmatic Paradigm
Low-Density Lipoprotein Cholesterol Targeting: A Continued Controversy